Session » Systemic Sclerosis & Related Disorders – Basic Science Poster II

Date: Monday, November 18, 2024

Time: 10:30AM-12:30PM

Meeting: ACR Convergence 2024

10:30AM-12:30PM: Abstract Number: 1817

Activated Macrophages Mediate Loss of Dermal White Adipose Tissue in Fibrotic Skin

10:30AM-12:30PM: Abstract Number: 1834

Altered Mechanotransduction via Myosin II Contributes to Collagen and IL-6 Production in Systemic Sclerosis Skin

10:30AM-12:30PM: Abstract Number: 1822

Analysis of Differential Activation of Lysophosphatidic Acid Regulated Genes in Diffuse and Limited Cutaneous Systemic Sclerosis

10:30AM-12:30PM: Abstract Number: 1827

Characterization of Fibroblast Subpopulations and Their Cellular Local Environments in Systemic Sclerosis Using Imaging Mass Cytometry

10:30AM-12:30PM: Abstract Number: 1820

Disruption of Ca2+ Homeostasis and Enhanced Ca2+ Signaling in Scleroderma Fibroblasts Is Due to the Vicious Cycle Formed by Mitochondrial-derived Reactive Oxygen Species, CaMKII, and ER Extrusion Pump RYR2

10:30AM-12:30PM: Abstract Number: 1818

Distribution and Morphological Changes of Adventitial Fibroblasts in Healthy and Scleroderma Skin

10:30AM-12:30PM: Abstract Number: 1829

Genomic Analysis of Skin Biopsies Differentiates Major Anti-Nuclear Autoantibody Subsets in Limited Cutaneous Systemic Sclerosis

10:30AM-12:30PM: Abstract Number: 1823

Identification and Prediction of Systemic Sclerosis Intrinsic Subtypes Using Semi-Supervised and Supervised Learning on Gene Expression Data of Multiple Cohorts

10:30AM-12:30PM: Abstract Number: 1833

Immune Complexes of Antibodies Directed to Angiotensin Receptor type-1 and Extracellular Vesicles Are Unique Modulators Contributing to Systemic Sclerosis

10:30AM-12:30PM: Abstract Number: 1819

Insulin-like Growth Factor Binding Protein-7 (IGFBP7) Plays a Pathogenic Role in Dermal Fibrosis and Is Increased in Systemic Sclerosis

10:30AM-12:30PM: Abstract Number: 1815

Leveraging Novel Systemic Sclerosis Disease Signatures to Build a Humanized Drug Discovery Funnel

10:30AM-12:30PM: Abstract Number: 1816

Paracrine WNT Signaling Drives Pro-fibrotic Metabolic Activation of Systemic Sclerosis Macrophages

10:30AM-12:30PM: Abstract Number: 1825

Proteomic and Transcriptomic Analysis Reveal Elevated Senescent Signature in Systemic Sclerosis Fibrosis

10:30AM-12:30PM: Abstract Number: 1831

Role of Long Non-Coding RNA H19 in Mediating Skin Fibrosis in Systemic Sclerosis

10:30AM-12:30PM: Abstract Number: 1830

Single-cell RNA Sequencing Profiling of Very Early-Stage Systemic Sclerosis Skin Reveals a Fibroblast Pro-inflammatory Gene Signature and Keratinocyte Dysregulation

10:30AM-12:30PM: Abstract Number: 1821

Single-Cell RNA SequencingBioinformatic Pipeline Optimized for Non-Coding GenesIdentified LINC01503 and MIR193-BHG as Potential Pathogenic Effectors in Systemic Sclerosis Fibroblasts

10:30AM-12:30PM: Abstract Number: 1824

Skin Macrophage Subtypes and Impact of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis: Results from Single-cell Analyses of an Observational Data Set and a Phase I/II Randomized Controlled Trial

10:30AM-12:30PM: Abstract Number: 1828

SSc Fibroblasts Trigger a Systemic Type I Interferon Response in SSc Patients Through Canonical TGF-β Receptor Signalling

10:30AM-12:30PM: Abstract Number: 1832

Targeting Hippo Pathway Diminishes Disease Signaling in Scleroderma Skin

10:30AM-12:30PM: Abstract Number: 1814

Understanding Monocyte Derived Macrophages in the Skin of SSc Patients Through Single Cell Analysis of Blister Fluid Immune Cell Populations

10:30AM-12:30PM: Abstract Number: 1826

Unveiling the Primary Cilia Signature Driving Systemic Sclerosis Pathogenesis

« View all sessions from this meeting